Applied UV Announces International Dealer Awarded Sole Source Provider Contract for Airocide's FDA Class II Listed Medical Device

Stock Information for Applied UV Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Applied UV Inc.

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $2.76 Million Registered Direct and Private Placement Priced at the Market for Applied UV, Inc. (NASDAQ: AUVI)
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
Applied UV's Subsidiary Files Patent Application for New Industry Disruptive Integrated Disinfection System for Healthcare Facilities
Applied UV's Subsidiary has Purchased the Continuing Business and a Multi-Year Exclusive Global Licensing Agreement With Element Designs
Applied UV, Inc. to Develop Smart Building Technologies for Larimar City, a New Luxury Development With Six Hotels and 20,000 High-end Residences - Potential Revenues Could Total $250 Million to $300 Million
Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?
Applied UV Inc. Announces Receipt of Provisional Patent for Our Pulse Modulated UVC LED System to be Added to Our Patented Fighter Flex LED Solution Expanding Significant Revenue Opportunity
Applied UV Inc. Announces Receipt of Significant Orders in Smart Building Technologies Division

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.